Cronos Group Inc. (NASDAQ:CRON) Shares Sold by Two Sigma Investments LP

Two Sigma Investments LP lowered its position in shares of Cronos Group Inc. (NASDAQ:CRON - Free Report) by 22.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,134,228 shares of the company's stock after selling 331,694 shares during the quarter. Two Sigma Investments LP owned approximately 0.30% of Cronos Group worth $2,291,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CRON. Shay Capital LLC increased its holdings in shares of Cronos Group by 79.6% in the fourth quarter. Shay Capital LLC now owns 55,413 shares of the company's stock valued at $112,000 after purchasing an additional 24,563 shares during the last quarter. Millennium Management LLC grew its holdings in Cronos Group by 23.7% in the 4th quarter. Millennium Management LLC now owns 840,374 shares of the company's stock valued at $1,698,000 after buying an additional 161,163 shares in the last quarter. D. E. Shaw & Co. Inc. increased its stake in shares of Cronos Group by 27.8% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 154,160 shares of the company's stock worth $310,000 after acquiring an additional 33,560 shares during the last quarter. Aquatic Capital Management LLC purchased a new position in shares of Cronos Group during the 4th quarter worth $148,000. Finally, Kerrisdale Advisers LLC raised its holdings in shares of Cronos Group by 2.3% during the 4th quarter. Kerrisdale Advisers LLC now owns 468,786 shares of the company's stock worth $947,000 after acquiring an additional 10,539 shares during the period. Hedge funds and other institutional investors own 8.71% of the company's stock.

Cronos Group Price Performance

Shares of NASDAQ CRON remained flat at $1.93 during midday trading on Wednesday. 1,415,944 shares of the stock were exchanged, compared to its average volume of 1,312,579. The stock has a market cap of $743.86 million, a PE ratio of -14.85, a P/E/G ratio of 1.74 and a beta of 1.06. The firm has a fifty day moving average of $1.88 and a 200 day moving average of $1.93. Cronos Group Inc. has a fifty-two week low of $1.60 and a fifty-two week high of $2.58.

Cronos Group (NASDAQ:CRON - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.01. The firm had revenue of $33.62 million during the quarter, compared to the consensus estimate of $45.44 million. Cronos Group had a negative net margin of 42.65% and a negative return on equity of 2.56%. On average, research analysts predict that Cronos Group Inc. will post -0.03 earnings per share for the current year.

Cronos Group Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.